Pharma IQ Members

Anti-Interferon

Anti-Interferon is an antibody to an interferon. It is used for the purification of interferons. The untoward effects of the interferons can be reversed or prevented by simultaneously adding anti-interferon (usually an antibody). This helps in treating many diseases, especially viral infections.

The R&D Race behind Immune Checkpoint Modulators

The cancer immunotherapy market is primed for growth, with Immune Checkpoint Inhibitors, otherwise known as Immune Checkpoint Modulators, representing one of the area’s newest and most promising treatments. While also incorporating the focus on...

Contributor: Chanice Henry
11/15/2015 07:00:00 PM EST
Pharma IQ News

The launch of interferon-free regimens is expected to boost the hepatitis C market from $2.9bn in 2013 to a peak of $19.2bn in 2016, according to independent analysts Datamonitor Healthcare.

The superior efficacy and tolerability of oral...

Contributor: Pharma IQ News
06/30/2014 08:00:00 PM EDT
Boehringer Ingelheim's Johannes Schoen on How to Prepare for the Falsified Medicines Directive

In this recent interview, Johannes Schoen, Supply Network Quality Management Anti-Counterfeitng, Boehringer Ingelheim speaks to Andrea Charles from Pharma IQ, following facilitating the "Anti-Counterfeiting: Falsified Medicines Directive and...

02/17/2013 07:00:00 PM EST
How Can We Still Deliver an Effective Anti-Counterfeiting Program When Facing Cost Restraints?

Cases of counterfeit pharmaceuticals being discovered entering the United States are on the up.

Up 200 percent to $11 million (£7 million) in 2011 to be precise, based on the domestic value of seizures from the Customs and Border Protection...

Contributor: Pharma IQ
01/26/2012 07:00:00 PM EST
Pharma IQ

"Fraudulent medicines offer organised criminal groups a high return commodity with relatively low risks, ultimately at the expense of the health of unsuspecting people," Yury Fedotov, executive director of the United Nations Office on Drugs and...

Contributor: Pharma IQ
06/08/2011 08:00:00 PM EDT
Jeffrey Gren

Jeffrey Gren, Director of the Office of Health and Consumer Goods, joins Pharma IQ to address some solutions to the increase in the volume and the level of sophistication of counterfeiting as part of the impact of the globalisation of the...

Contributor: Jeffrey Gren
05/26/2011 08:00:00 PM EDT
Pharma IQ News

Cranbury, New Jersey, May 24, 2011- Systech International, innovator of Packaging Execution Systems (PES), and our Brazilian Partner Videojet today announced that one of the world’s largest pharmaceutical manufacturers has chosen to implement...

Contributor: Pharma IQ News
05/24/2011 08:00:00 PM EDT
Helen Winsor

Mark Gibson, Consumer Information Specialist at Gibson Research Consultancy, joins Helen Winsor form Pharma IQ, to discuss packaging and labelling in the healthcare industry. In this exclusive interview, Gibson outlines the main considerations in...

Contributor: Helen Winsor
05/08/2011 08:00:00 PM EDT
Andrea Charles

Chandrashekhar Krishnan, Executive Director of Transparency International (UK), joins Pharma IQ to discuss the Bribery Act, which is currently under review by the UK Government. The government has delayed the implementation of the Act to allow...

Contributor: Andrea Charles
03/01/2011 07:00:00 PM EST
Andrea Charles

Jim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ, to discuss the challenge of pharmaceutical counterfeiting.Pharma IQ: Could you outline the importance of the EAASM and any important projects you’ve been involved...

Contributor: Andrea Charles
02/27/2011 07:00:00 PM EST
Pharma IQ

With the performance of new and existing IPs potentially being the difference between success and failure in the modern business world, it is arguably more important than ever that these are protected from criminals. Counterfeiters are constantly...

Contributor: Pharma IQ
02/16/2011 07:00:00 PM EST
Helen Winsor

James McBlane, Preclinical Assessor in the Clinical Trials Unit, Medicines & Healthcare products Regulatory Agency (MHRA), joins Pharma IQ to discuss clinical trials in patients with advanced cancer, ahead of the 2nd Annual Optimising...

Contributor: Helen Winsor
01/17/2011 07:00:00 PM EST
Pharma IQ News

Mark Edwards, Global Freight Manager from Actavis and John Franks, Security Director EMEA from Merck Sharp & Dohme, joined forces in order to explore how patient safety could be improved by protecting pharmacies and distributors from supply...

Contributor: Pharma IQ News
01/04/2011 07:00:00 PM EST
Helen Winsor

Sébastien Mauel, Head of Product Security at Ares Trading SA, an affiliate of Merck Serono SA, joins Pharma IQ to discuss anti-counterfeiting.Pharma IQ: How severe would you say the counterfeiting situation is within the pharmaceutical industry...

Contributor: Helen Winsor
12/13/2010 07:00:00 PM EST
Pharma IQ News

According to a new survey published by Pharma IQ on pharmaceutical anti-counterfeiting 61.5 percent respondents found that the threat of counterfeit medicines this year is more severe than ever and 53 percent admitted that they are planning to...

Contributor: Pharma IQ News
12/13/2010 07:00:00 PM EST
Pharma IQ

Jim Thomson, Chair of the European Alliance for Access to Safer Medicines (EAASM), discusses the implications of the EU Pharma package with Helen Winsor from Pharma IQ. Thomson explains how pharmaceutical packaging and anti-counterfeiting...

Contributor: Pharma IQ
09/28/2010 08:00:00 PM EDT
Pharma IQ

Christoph Krahenbuhl, IS Programme Manager for Pack Coding and Product Security at AstraZeneca, talks to Helen Winsor from Pharma IQ, about the challenges associated with pharmaceutical serialisation and traceability and how they are being...

Contributor: Pharma IQ
09/20/2010 08:00:00 PM EDT
Pharma IQ

Counterfeit medicines present a serious challenge for the pharmaceutical industry. As well as the dangers to public health presented by such drugs, the presence of counterfeit medicines serves to reduce confidence within the pharmaceutical...

Contributor: Pharma IQ
09/07/2010 08:00:00 PM EDT
Pharma IQ News

New York, New York, IQPC presents the 2nd Anti-Infectives Summit taking place September 27 -29th, 2010 in San Francisco, CA. In the next five years the global market for anti-infective drugs is projected to increase by over 50%, there is great...

Contributor: Pharma IQ News
07/21/2010 08:00:00 PM EDT